Article
SETD2 methyltransferase activity promotes correct transcription initiation and termination.
EMBO reports - 1 May 2026
Kopczyńska Magda, Nakayama Chihiro, Stępień Agata, Ito Shoko, Imami Koshi, Gdula Michał R, Nojima Takayuki, Kamieniarz-Gdula Kinga
Abstract excerpt
SETD2 is a methyltransferase responsible for depositing histone H3 lysine 36 trimethylation (H3K36me3). Loss of its enzymatic activity occurs in some cancers, including renal cell carcinoma. SETD2 mutations have been linked to delayed transcription termination but have not been explored in depth. Here, using nascent transcriptomics in SETD2 knockout and patient-derived cells, we reveal a dichotomy in SETD2...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
